Literature DB >> 29698746

Mortality, morbidity and 2-years neurodevelopmental prognosis of twin to twin transfusion syndrome after fetoscopic laser therapy: a prospective, 58 patients cohort study.

Mélanie Korsakissok1, Marion Groussolles2, Odile Dicky3, Corinne Alberge4, Charlotte Casper3, Corinne Azogui-Assouline4.   

Abstract

OBJECTIVE: To describe the morbidity and mortality and long-term neurodevelopmental outcomes in children born from a Twin-to-Twin Transfusion Syndrome (TTTS) pregnancy treated using laser fetoscopy in Toulouse. POPULATION AND
METHOD: All pregnancies with TTTS treated by laser fetoscopy in our centre were included. Antenatal and postnatal morbidity and neonatal morbidity were identified in the medical records retrospectively. The neurodevelopmental outcome was studied using Ages and Stages Questionnaires (ASQ) sent to the parents, an oral interview with the parents and with the child's doctor (last objective neurological examination, rehabilitation needs, learning disabilities).
RESULTS: Seventy-one pregnancies, or 144 foetuses, were included from 2008 to 2014, overall survival at 2 years was 72.9% and the survival of at least one child at 2 years was 91.5%, severe neonatal morbidity was 11.2% of the children, severe brain damage accounted for 3.6% of children admitted to the hospital unit. It was possible to study the neurodevelopmental outcome for 58 children (55.3%), with a corrected age from 24 to 95 months. Five children (8.6%) had severe neurological abnormalities and 17 (29.3%) had moderate neurological abnormalities. DISCUSSION: The mortality, neonatal morbidity and long-term neurological morbidity of our cohort are higher than those of premature infants (EPIPAGE-2 French cohort), which confirms the severity of this syndrome, and are comparable to those of the TTTS cohorts described in the literature.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Laser fetoscopy; Long-term neurodevelopment; Mortality; Neonatal morbidity; Prematurity; Twin-to-Twin Transfusion Syndrome

Mesh:

Year:  2018        PMID: 29698746     DOI: 10.1016/j.jogoh.2018.04.003

Source DB:  PubMed          Journal:  J Gynecol Obstet Hum Reprod        ISSN: 2468-7847


  3 in total

1.  Fetoscopic Laser Ablation for the Selective Fetal Reduction in Twin-Twin Transfusion Syndrome Stage II-IV: The Experience of a New Fetal Medicine Center.

Authors:  Nguyen Duy Anh; Ho Sy Hung; Nguyen Thi Sim; Nguyen Thi Thu Ha; Duc Lam Nguyen; Nguyen Duy Bac; Hoang Van Tong; Yves Ville; Phan Thi Huyen Thuong
Journal:  Int J Womens Health       Date:  2022-04-14

2.  Long-Term Neurodevelopmental Outcome in Twin-to-Twin Transfusion Syndrome: Is there still Room for Improvement?

Authors:  Marjolijn S Spruijt; Enrico Lopriore; Ratna N G B Tan; Femke Slaghekke; Frans J C M Klumper; Johanna M Middeldorp; Monique C Haak; Dick Oepkes; Monique Rijken; Jeanine M M van Klink
Journal:  J Clin Med       Date:  2019-08-15       Impact factor: 4.241

3.  Pregnancy and parenting experiences of women with twin-to-twin transfusion syndrome: a qualitative study.

Authors:  Yan Yang; Shaowei Yin; Lijie Ren; Cancan Song; Chunling Xia; Nan Wang
Journal:  BMC Pregnancy Childbirth       Date:  2021-09-03       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.